As expected, vehicle‐treated 5xFAD mice displayed proteomic signatures consistent with AD progression, including upregulation of App, apoE, Gfap, and C1qa, along with enrichment of immune response, proteostasis, lipid metabolism, apoptosis, and APP metabolism pathways. The gene discussed is C1QA; the disease is Alzheimer disease.